Clinical Trial Update: The Effect of Probiotics ATG-F4 in Cancer Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating the probiotic ATG-F4 in patients with pancreatic cancer and colorectal cancer; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Pancreatic Cancer

Drugs mentioned

• ATG-F4 (ATG-F4 probiotic)

Snippet

Sponsor: Chungnam National University Hospital | Conditions: Pancreatic Cancer, Colon Cancer | Phase 2 | Status: RECRUITING